Gelonghui August 22nd Hongli Medical Management (09906.HK) announcementInterim results for the six months ended June 30, 2022Realized by the companyIncome 375 million yuan，A year-on-year increase of 30.8%The profit attributable to the owner of the company during the period is 32.173 million yuan.Year-on-year increase62.3%；Basic and diluted earnings per share of 0.05 yuan。

IncomeIncreaseThis is mainly due to increased revenue from treatment and integrated medical services and drug sales. The main reasons are: (I) after the first phase of the building was put into use, new diagnostic equipment was added, which provided a more comprehensive and reliable diagnosis basis for clinic; (ii) improved the information diagnosis and treatment process and shortened the waiting time; (iii) expanded the medical room area and beautified the medical environment; (iv) the introduction of talents and the application of a number of new technologies improved the medical quality. Patients' medical experience has been improved, and the amount of service has increased significantly. It shows that the Group has a strong ability to withstand risks.